0

531380

CSURGSU

img img img img
No Data Available

CENTENIAL SURGICAL SUTURE LTD. Share Price Update

As of the latest trading session, CENTENIAL SURGICAL SUTURE LTD. is trading at ₹104.2, up by ₹4.94 or 4.97% from its previous close. The stock has moved between ₹104.20 and ₹104.20 today. Over the past year, the stock has delivered a return of -23.85%. In the last month, it has returned 30.12%.

Investment Returns

Over 1 Month 30.12% Over 3 Months 7.52% Over 6 Months -7.24% Over 1 Year -23.85%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CENTENIAL SURGICAL SUTURE LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 38.00
  • P/E Ratio (TTM) -33.31
  • Beta -0.23
  • Book Value / share 79.26
  • Return on equity -4.64%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.15
info icon alternate text

CENTENIAL SURGICAL SUTURE LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 14.86
Operating Expense 14.71
Net Profit 0.15
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 0.40
EBITDA 1.59
Effective Tax Rate (%) 25.00
Particulars SEP 2025 (Values in Cr)
Revenue 13.46
Operating Expense 13.51
Net Profit -0.01
Net Profit Margin (%) -0.07
Earnings Per Share (EPS) -0.03
EBITDA 1.44
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 12.94
Operating Expense 12.98
Net Profit -0.04
Net Profit Margin (%) -0.30
Earnings Per Share (EPS) -0.11
EBITDA 1.23
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 13.31
Operating Expense 14.69
Net Profit -1.18
Net Profit Margin (%) -8.86
Earnings Per Share (EPS) -3.24
EBITDA 2.11
Effective Tax Rate (%) 11.19
Particulars DEC 2024 (Values in Cr)
Revenue 12.20
Operating Expense 13.05
Net Profit -0.85
Net Profit Margin (%) -6.96
Earnings Per Share (EPS) -2.30
EBITDA 0.76
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 53.52
Operating Expense 55.26
Net Profit -1.46
Net Profit Margin (%) -2.72
Earnings Per Share (EPS) -4.01
EBITDA 6.38
Effective Tax Rate (%) 9.25
Particulars MAR 2024 (Values in Cr)
Revenue 51.19
Operating Expense 50.04
Net Profit 1.13
Net Profit Margin (%) 2.20
Earnings Per Share (EPS) 3.11
EBITDA 5.13
Effective Tax Rate (%) 11.02
Particulars MAR 2023 (Values in Cr)
Revenue 52.66
Operating Expense 51.31
Net Profit 1.00
Net Profit Margin (%) 1.89
Earnings Per Share (EPS) 2.43
EBITDA 4.42
Effective Tax Rate (%) 31.50
Particulars MAR 2022 (Values in Cr)
Revenue 44.43
Operating Expense 43.39
Net Profit 0.63
Net Profit Margin (%) 1.41
Earnings Per Share (EPS) 1.72
EBITDA 4.49
Effective Tax Rate (%) 42.05
Particulars MAR 2021 (Values in Cr)
Revenue 36.93
Operating Expense 35.50
Net Profit 0.96
Net Profit Margin (%) 2.59
Earnings Per Share (EPS) 2.64
EBITDA 5.10
Effective Tax Rate (%) 37.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 56.70
ROE % -4.64
ROCE % 3.65
Total Debt to Total Equity 0.85
EBITDA Margin 12.22
Particulars MAR 2024 (Values in Cr)
Book Value / Share 59.40
ROE % 3.57
ROCE % 7.23
Total Debt to Total Equity 0.52
EBITDA Margin 10.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.31
ROE % 2.91
ROCE % 6.95
Total Debt to Total Equity 0.31
EBITDA Margin 8.60
Particulars MAR 2022 (Values in Cr)
Book Value / Share 55.67
ROE % 2.11
ROCE % 6.22
Total Debt to Total Equity 0.38
EBITDA Margin 10.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 54.52
ROE % 3.30
ROCE % 7.28
Total Debt to Total Equity 0.45
EBITDA Margin 14.08
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 84.58
Total Liabilities 84.58
Total Equity 30.75
Share Outstanding 0
Price to Book Ratio 1.94
Return on Assets (%) -1.73
Return on Capital (%) -2.41
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.68
Total Assets 79.15
Total Liabilities 79.15
Total Equity 32.21
Share Outstanding 0
Price to Book Ratio 1.54
Return on Assets (%) 1.43
Return on Capital (%) 2.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.33
Total Assets 66.40
Total Liabilities 66.40
Total Equity 31.08
Share Outstanding 0
Price to Book Ratio 1.08
Return on Assets (%) 1.33
Return on Capital (%) 2.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 61.33
Total Liabilities 61.33
Total Equity 30.19
Share Outstanding 0
Price to Book Ratio 1.09
Return on Assets (%) 1.02
Return on Capital (%) 1.59
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.53
Total Assets 70.04
Total Liabilities 70.04
Total Equity 29.57
Share Outstanding 0
Price to Book Ratio 0.78
Return on Assets (%) 1.37
Return on Capital (%) 2.23
Particulars MAR 2025 (Values in Cr)
Net Income -1.61
Cash from Operations 17.33
Cash from Investing -11.60
Cash from Financing -5.93
Net change in Cash -0.46
Free Cash Flow 28.80
Particulars MAR 2024 (Values in Cr)
Net Income 1.27
Cash from Operations 6.62
Cash from Investing -7.91
Cash from Financing 2.05
Net change in Cash 0.35
Free Cash Flow 14.32
Particulars MAR 2023 (Values in Cr)
Net Income 1.46
Cash from Operations 1.84
Cash from Investing -0.17
Cash from Financing -1.04
Net change in Cash 0.07
Free Cash Flow 2.00
Particulars MAR 2022 (Values in Cr)
Net Income 1.07
Cash from Operations 5.05
Cash from Investing -0.16
Cash from Financing -4.86
Net change in Cash -0.28
Free Cash Flow 5.20
Particulars MAR 2021 (Values in Cr)
Net Income 1.52
Cash from Operations 2.53
Cash from Investing -0.88
Cash from Financing -1.26
Net change in Cash -0.18
Free Cash Flow 3.37
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7639.20 60.47 12.08 109839.98 6680.00 8099.00
FORTIS MALAR HOSPITALS LIMITED 56.00 23.14 3.05 104.95 40.75 81.00
SHREE PACETRONIX LTD. 135.36 20.42 2.99 50.76 66.10 283.15
TRANSGENE BIOTEK LTD. 2.75 0.00 2.26 20.84 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7639.20 75.63 11.79 109839.98 6680.00 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.20 0.00 -11.39 29.28 30.02 57.48
KOVAI MEDICAL CENTER & HO 5665.45 26.28 5.20 6198.00 5010.00 6725.00

CENTENIAL SURGICAL SUTURE LTD. shareholding pattern

Holding
53.11%
46.88%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

CENTENIAL SURGICAL SUTURE LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
104.20 4.98 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 98.30
  • 26 Days 92.50
  • 10 Days 96.20
  • 50 Days 92.70
  • 12 Days 95.40
  • 100 Days 97.00
  • 20 Days 93.20
  • 200 Days 104.80
99.41 PIVOT
First Support 99.09 First Resistance 99.58 Second Support 98.92 Second Resistance 99.90 Third Support 98.60 Third Resistance 100.07
RSI 57.12 ADX 20.70 MACD 2.83 Williams % R -20.86 Commodity Channel Index (CCI) 84.88
Date 2026-04-27 Week 108.00 Same Day 247.00 Month 107.00
1 Year -0.24 3 Year 0.08
Over 1 Month
30.12% down
Over 1 Year
-23.85% down
Over 3 Months
7.52% down
Over 3 Years
15.74% down
Over 6 Months
-7.24% down
Over 5 Years
18.85% down

CENTENIAL SURGICAL SUTURE LTD. Corporate Actions

Top Gainers

Top Losers

CENTENIAL SURGICAL SUTURE LTD. Share Price

Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India. The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes. It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable.

Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons. Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company. Within the cardiovascular division, Centenial offers a wide range of product codes which includes over 300 codes produced catalogue that cover applications for CABG. Company enjoys deep manufacturing capabilities and know-how in Cardiovascular Sutures, materials and atraumatic needles, that makes it a trusted partner.

Centenial competes with many domestic and foreign medical device companies ranging from small start-up enterprises that might sell only a single or limited number of competitive products or compete only in a specific market segment, to companies that are larger and more established than, have a broad range of competitive products, participate in numerous markets, tenders and have access to significantly greater financial and marketing resources than Centenial . In addition, the medical device industry is characterized by extensive product research and development and rapid technological advances.

Parent organization Indian Private
NSE symbol [-]
Founded 1995
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Centenial Surgical Suture Ltd?

Answer Field

Centenial Surgical Suture Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 104.20 as on May 04 2026 09:17 AM.

What is the Market Cap of Centenial Surgical Suture Ltd Share?

Answer Field

The market cap of Centenial Surgical Suture Ltd for NSE ₹ 0.00 & for BSE ₹ 38.00 as on May 04 2026 09:17 AM.

What is the 52 Week High and Low of Centenial Surgical Suture Ltd?

Answer Field

The 52 Week High and Low of Centenial Surgical Suture Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 189.00 and ₹ 76.27.

What is 1 year return for Centenial Surgical Suture Ltd?

Answer Field

The 1 year returns on the stock has been -23.85%.

What is the P/E Ratio of Centenial Surgical Suture Ltd Share?

Answer Field

As on May 04 2026 09:17 AM the price-to-earnings (PE) ratio for Centenial Surgical Suture Ltd share is -33.31.

What is the PB ratio of Centenial Surgical Suture Ltd Share?

Answer Field

As on May 04 2026 09:17 AM, the price-to-book (PB) ratio for Centenial Surgical Suture Ltd share is 79.26.

How to Buy Centenial Surgical Suture Ltd Share?

Answer Field

You can trade in Centenial Surgical Suture Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Centenial Surgical Suture Ltd Share on Bajaj Broking App?

Answer Field

To buy Centenial Surgical Suture Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Centenial Surgical Suture Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|